FDA Approves CHILDRENS IBUPROFEN — Chain Drug Marketing Association Inc.

Chain Drug Marketing Association Inc. has received approval from the U.S. Food and Drug Administration to launch a generic version of Children’s Ibuprofen, offering market competition that may drive down over-the-counter pricing. This latest ANDA approval expands the availability of essential pain relief medication for caregivers and is expected to stabilize costs amid the ongoing shortage of children’s medicines.